Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies
NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC
Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects
Controlling Diabetes May Cut Liver Cancer Risk, Study Finds
Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds
Healthcare Utilization Figures More Than Biology In Disparity
Phase III Lung and Pancreatic Cancer Trials Are Stopped
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- “Father of tamoxifen” V. Craig Jordan dies at 76
- NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
- Discovery of EGFR mutations dramatically changed lung cancer treatment
20th anniversary of landmark findings
